Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma

被引：0
|
作者：
Da Hyun Kang
Sung Soo Jung
Min-Kyung Yeo
Da Hye Lee
Geon Yoo
Sang Yeon Cho
In-Jae Oh
Ju-Ock Kim
Hee Sun Park
Chaeuk Chung
Jeong Eun Lee
机构：
[1] College of Medicine,Division of Pulmonology, Department of Internal Medicine
[2] Chungnam National University,Department of Pathology, College of Medicine
[3] Chungnam National University,Department of Internal Medicine
[4] Korea Institute of Toxicology,undefined
[5] Chungnam National University School of Medicine,undefined
[6] Chonnam National University Medical School,undefined
来源：
BMC Cancer | / 20卷
关键词：
Mig-6; EGFR-TKI; Lung adenocarcinoma; Chemotherapy resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] EGFR-TKI FOR LUNG CANCER
    Bai, Chunxue
    RESPIROLOGY, 2010, 15 : 23 - 23
  • [32] Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation
    Izumi, Hiroto
    Kanda, Rina
    Murakami, Yuichi
    Morimoto, Yasuo
    Ono, Mayumi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [33] Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation
    Izumi, Hiroto
    Kanda, Rina
    Murakami, Yuichi
    Morimoto, Yasuo
    Ono, Mayumi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [34] Advances in the management of acquired resistance to EGFR-TKI in non-small cell lung cancer
    Fei Zhou
    Caicun Zhou
    Oncology and Translational Medicine, 2015, 1 (01) : 20 - 25
  • [35] REBIOPSY IN NON-SMALL CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI
    Yamauchi, Hiroyoshi
    Nakayama, Masayuki
    Yamamoto, Shinichi
    Saito, Tatsuya
    Okuyama, Akiko
    Mato, Naoko
    Yamasawa, Hideaki
    Suzuki, Takuji
    Bando, Masashi
    Hagiwara, Koichi
    RESPIROLOGY, 2017, 22 : 242 - 242
  • [36] Temporal Heterogeneity of Resistance Mechanisms to EGFR-TKI Identified in a Patient With Lung Adenocarcinoma and Sarcomatoid Transformation
    Zheng, Jinyang
    Zhu, Jinfeng
    Zhang, Kelian
    Yuan, Mingming
    Chen, Mujin
    Chen, Rongrong
    Li, Xiaofeng
    CLINICAL LUNG CANCER, 2020, 21 (04) : E255 - E257
  • [37] Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance
    Zhang, Chuanfen
    Wang, Chunmei
    Yang, Zhenyu
    Bai, Yuquan
    Shukuya, Takehito
    Poh, Mau-Ern
    Ekman, Simon
    Li, Jian
    Xu, Yuyang
    Deng, Senyi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (05) : 786 - +
  • [38] MYC expression and fatty acid oxidation in EGFR-TKI acquired resistance
    Wang, GuoSheng
    Li, Tao
    Wan, Yuan
    Li, Qiang
    DRUG RESISTANCE UPDATES, 2024, 72
  • [39] Peritoneal relapse from lung adenocarcinoma after a response to EGFR-TKI
    Satoh, Hiroaki
    Kagohashi, Katsunori
    Kurishima, Koichi
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2013, 61 (04): : 346 - 347
  • [40] Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients
    Chung, Chi-Li
    Lee, Kai-Ling
    Hsiao, Shih-Hsin
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
12345